EGFR and prostate carcinoma: They include the prostate cancer suppressor NXK3-1 [19], the gene CSMD1, which is recurrently deleted in melanoma [11], and the phosphatase DUSP4, which is involved in negative feedback control of EGFR signaling in lung adenocarcinoma [20].